Interventional Radiology Treatment for Postoperative Chylothorax
نویسندگان
چکیده
منابع مشابه
Interventional radiology treatment for pulmonary embolism
Venous thromboembolism (VTE) is an illness that has a potentially life-threatening condition that affects a large percentage of the global population. VTE with pulmonary embolism (PE) is the third leading cause of death after myocardial infarction and stroke. In the first three months after an acute PE, there is an estimated 15% mortality among submassive PE, and 68% mortality in massive PE. Cu...
متن کاملRadiotherapy in the treatment of postoperative chylothorax
BACKGROUND Chylothorax is characterized by the presence of chyle in the pleural cavity. The healing rate of non-operative treatment varies enormously; the maximum success rate in series is 70%. We investigate the efficacy and outcomes of radiotherapy for postoperative chylothorax. METHODS Chylothorax was identified based on the quantity and quality of the drainage fluid. Radiation was indicat...
متن کاملInterventional Chest Radiology
Transthoracic needle biopsy (TNB) of pulmonary nodules requires the skills of two specialists: (1) the radiologist and (2) the pathologist. From the radiologist’s perspective, the goal is very simple: to obtain a sufficient amount of material through the needle to allow the pathologist to make a diagnosis with a minimum of complications to the patient. Similarly, the goal of the pathologist is ...
متن کاملSouth East Asian Society of Interventional Radiology (SEASIR): state and future of radiology in interventional radiology
The empires of the future are the empires of the mind.-Sir Winston Churchill Healthcare is widely viewed as an essential service and even a right of all members of society. Global dynamic changes within the past decade in the legislative, financial and technological areas have had a dramatic effect on the practice of radiology. Interventional radiology is no exception. The provision of basic he...
متن کاملInterventional Radiology and Hcc
Hepatocellular cancer (hcc) is the 2nd most frequent cause of cancer-related death in men and the 6th in women1. In 2008, the number of new liver cancer cases was estimated to be 748,300 worldwide, and 695,900 deaths were attributed to liver cancer that same year1. Overall, liver transplantation, surgical resection, and locoregional therapies are the treatment options for hcc. However, only a s...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Korean Journal of Thoracic and Cardiovascular Surgery
سال: 2020
ISSN: 2233-601X,2093-6516
DOI: 10.5090/kjtcs.2020.53.4.200